Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion type Assertion NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_head.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion wasGeneratedBy ECO_0000203 NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion wasDerivedFrom gad-20130706 NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion SIO_000772 19960344 NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion evidence source_evidence_literature NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.
- NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_assertion description "[To evaluate the effect of excision repair cross-complementing group 1 (ERCC1) and X-ray cross-complementing group 1 (XRCC1) gene polymorphisms on treatment outcome in patients receiving oxaliplatin-based regimens for metastatic colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP44945.RAk1t0D_21JlmaZJ3fWbaHeaBLmtk6sG9rbeIhGfMBrzw130_provenance.